TABLE OF CONTENTS
|  | | | Volume 110, Issue 9 (2165-2388)
Published online 29 April 2014
|  | In this issue
 Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology
Also new today
 Advance online publication
Digital Edition
| | | | | | Advertisement | | | | | | Clinical Studies | Top | | Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer L Fornaro, S Cereda, G Aprile, S Di Girolamo, D Santini, N Silvestris, S Lonardi, F Leone, M Milella, C Vivaldi, C Belli, F Bergamo, S E Lutrino, R Filippi, M Russano, V Vaccaro, A E Brunetti, V Rotella, A Falcone, M A Barbera, J Corbelli, G Fasola, M Aglietta, V Zagonel, M Reni, E Vasile and G Brandi Br J Cancer 2014 110: 2165-2169; advance online publication, April 8, 2014; 10.1038/bjc.2014.190 Abstract | Full Text | | | | A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours F A L M Eskens, P Tresca, D Tosi, L Van Doorn, H Fontaine, A Van der Gaast, C Veyrat-Follet, C Oprea, M Hospitel and V Dieras Br J Cancer 2014 110: 2170-2177; advance online publication, April 8, 2014; 10.1038/bjc.2014.137 Abstract | Full Text | | | | A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine? T S Maughan, A M Meade, R A Adams, S D Richman, R Butler, D Fisher, R H Wilson, B Jasani, G R Taylor, G T Williams, J R Sampson, M T Seymour, L L Nichols, S L Kenny, A Nelson, C M Sampson, E Hodgkinson, J A Bridgewater, D L Furniss, R Roy, M J Pope, J K Pope, M Parmar, P Quirke and R Kaplan Br J Cancer 2014 110: 2178-2186; advance online publication, April 17, 2014; 10.1038/bjc.2014.182 Abstract | Full Text | | | | Spectrum of very early breast cancer in a setting without organised screening N Bhoo-Pathy, S Subramaniam, N A Taib, M Hartman, Z Alias, G-H Tan, R I Ibrahim, C-H Yip and H M Verkooijen Br J Cancer 2014 110: 2187-2194; advance online publication, April 15, 2014; 10.1038/bjc.2014.183 Abstract | Full Text | | | | Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma C Daveau, S Baulies, M Lalloum, M Bollet, B Sigal-Zafrani, X Sastre, A Vincent-Salomon, A Tardivon, F Thibault, J Y Pierga, P Cottu, M P Sablin, R Rouzier, C Malhaire, P Mallon and F Reyal Br J Cancer 2014 110: 2195-2200; advance online publication, April 8, 2014; 10.1038/bjc.2014.143 Abstract | Full Text | | | | Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer A G de Liaño, O Reig, B Mellado, C Martin, E U Rull and J P Maroto Br J Cancer 2014 110: 2201-2208; advance online publication, April 10, 2014; 10.1038/bjc.2014.189 Abstract | Full Text | | | | Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy M I Koukourakis, A Giatromanolaki, A Bottini, M R Cappelletti, L Zanotti, G Allevi, C Strina, M Ardine, M Milani, G Brugnoli, M Martinotti, G Ferrero, R Bertoni, F Ferrozzi, A L Harris and D Generali Br J Cancer 2014 110: 2209-2216; advance online publication, April 10, 2014; 10.1038/bjc.2014.196 Abstract | Full Text | | Translational Therapeutics | Top | | Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy M I Koukourakis, A Giatromanolaki, M Panteliadou, S E Pouliliou, P S Chondrou, S Mavropoulou and E Sivridis Br J Cancer 2014 110: 2217-2223; advance online publication, April 8, 2014; 10.1038/bjc.2014.158 Abstract | Full Text | | | | Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents M N Saha, Y Chen, M-H Chen, G Chen and H Chang Br J Cancer 2014 110: 2224-2231; advance online publication, April 1, 2014; 10.1038/bjc.2014.164 Abstract | Full Text | | | | Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma J Yamamoto, K Ohnuma, R Hatano, T Okamoto, E Komiya, H Yamazaki, S Iwata, N H Dang, K Aoe, T Kishimoto, T Yamada and C Morimoto Br J Cancer 2014 110: 2232-2245; advance online publication, April 17, 2014; 10.1038/bjc.2014.151 Abstract | Full Text | | Molecular Diagnostics | Top | | Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas N Mäkinen, H-R Heinonen, J Sjöberg, J Taipale, P Vahteristo and L A Aaltonen Br J Cancer 2014 110: 2246-2249; advance online publication, March 18, 2014; 10.1038/bjc.2014.138 Abstract | Full Text | | | | GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma Y Xue, G Wu, Y Liao, G Xiao, X Ma, X Zou, G Zhang, R Xiao, X Wang, Q Liu, D Long, J Yang, H Xu, F Liu, M Liu, K Xie and R Huang Br J Cancer 2014 110: 2250-2260; advance online publication, March 4, 2014; 10.1038/bjc.2014.124 Abstract | Full Text | | | | High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma H An, L Xu, Y Zhu, T Lv, W Liu, Y Liu, H Liu, L Chen, J Xu and Z Lin Br J Cancer 2014 110: 2261-2268; advance online publication, April 8, 2014; 10.1038/bjc.2014.179 Abstract | Full Text | | | | Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine T Golan, D Atias, I Barshack, C Avivi, R S Goldstein and R Berger Br J Cancer 2014 110: 2269-2276; advance online publication, March 25, 2014; 10.1038/bjc.2014.123 Abstract | Full Text | | | | Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma M Teng, S Pirrie, D G Ward, L K Assi, R G Hughes, D Stocken and P J Johnson Br J Cancer 2014 110: 2277-2282; advance online publication, March 6, 2014; 10.1038/bjc.2014.121 Abstract | Full Text | | | | Notch1 activation is a poor prognostic factor in patients with gastric cancer H Zhang, X Wang, J Xu and Y Sun Br J Cancer 2014 110: 2283-2290; advance online publication, March 18, 2014; 10.1038/bjc.2014.135 Abstract | Full Text | | | | A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer C Zhu, C Ren, J Han, Y Ding, J Du, N Dai, J Dai, H Ma, Z Hu, H Shen, Y Xu and G Jin Br J Cancer 2014 110: 2291-2299; advance online publication, March 4, 2014; 10.1038/bjc.2014.119 Abstract | Full Text | | | | MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1 Y Feng, J Zhu, C Ou, Z Deng, M Chen, W Huang and L Li Br J Cancer 2014 110: 2300-2309; advance online publication, March 18, 2014; 10.1038/bjc.2014.122 Abstract | Full Text | | | | TAp63 suppress metastasis via miR-133b in colon cancer cells C W Lin, X R Li, Y Zhang, G Hu, Y H Guo, J Y Zhou, J Du, L Lv, K Gao, Y Zhang and H Deng Br J Cancer 2014 110: 2310-2320; advance online publication, March 4, 2014; 10.1038/bjc.2014.118 Abstract | Full Text | | Epidemiology | Top | | Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom K E Bradbury, A Balkwill, E A Spencer, A W Roddam, G K Reeves, J Green, T J Key, V Beral, K Pirie and The Million Women Study Collaborators Br J Cancer 2014 110: 2321-2326; advance online publication, March 27, 2014; 10.1038/bjc.2014.148 Abstract | Full Text | | | | Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis P Chen, C Li, X Li, J Li, R Chu and H Wang Br J Cancer 2014 110: 2327-2338; advance online publication, March 25, 2014; 10.1038/bjc.2014.155 Abstract | Full Text | | | | Cigarette smoking and postmenopausal breast cancer risk in a prospective cohort S J Nyante, G L Gierach, C M Dallal, N D Freedman, Y Park, K N Danforth, A R Hollenbeck and L A Brinton Br J Cancer 2014 110: 2339-2347; advance online publication, March 18, 2014; 10.1038/bjc.2014.132 Abstract | Full Text | | | | Cholecystectomy, gallstones, tonsillectomy, and pancreatic cancer risk: a population-based case-control study in minnesota J Zhang, A E Prizment, I B Dhakal and K E Anderson Br J Cancer 2014 110: 2348-2353; advance online publication, March 25, 2014; 10.1038/bjc.2014.154 Abstract | Full Text | | | | Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort study W-Y Huang, C-H Muo, C-Y Lin, Y-M Jen, M-H Yang, J-C Lin, F-C Sung and C-H Kao Br J Cancer 2014 110: 2354-2360; advance online publication, February 25, 2014; 10.1038/bjc.2014.103 Abstract | Full Text | | | | Does cancer risk increase with HbA1c, independent of diabetes? J C de Beer and L Liebenberg Br J Cancer 2014 110: 2361-2368; advance online publication, March 27, 2014; 10.1038/bjc.2014.150 Abstract | Full Text | | | | Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis J L Petrick, A B Wyss, A M Butler, C Cummings, X Sun, C Poole, J S Smith and A F Olshan Br J Cancer 2014 110: 2369-2377; advance online publication, March 11, 2014; 10.1038/bjc.2014.96 Abstract | Full Text | | | | Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a meta-analysis S Zhang, X-Q Zhang, X-W Ding, R-K Yang, S-L Huang, F Kastelein, M Bruno, X-J Yu, D Zhou and X-P Zou Br J Cancer 2014 110: 2378-2388; advance online publication, March 20, 2014; 10.1038/bjc.2014.127 Abstract | Full Text | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment